Susetrigine approval could boost growth News ad
Vertex Pharmaceuticals NASDAQ: VRTX is a biotechnology company with a long history of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the pain management sector, providing an attractive growth opportunity for the company and its investors. As the global market seeks effective, non-opioid pain treatments, Vertex’s advances in this area … Read more
